TERT and hepatocellular carcinoma: In addition, we observed a significant increase in the status of TP53 mutations (P < 0.012, Table S1), TERT mutations (P = 0.018, Table S1), and ARID1A mutations (P = 0.047, Table S1) in HCC patients obtaining genetic changes of m6A genes.